Back to Explorer

Study and Evaluation of Sex Differences in the Clinical Evaluation of Drugs: Guidance for Industry

FinalCenter for Drug Evaluation and Research07/22/1993

Description

The FDA published Good Guidance Practices in February 1997. This guidance was developed and issued prior to that date.

Scope & Applicability

Product Classes

1
Drugs

Clinical investigations of drugs, including human drugs and biological products

Related CFR Sections (1)

See Also (8)

Study and Evaluation of Sex Differences in the Clinical Evaluation of Drugs: Guidance for Industry | Guideline Explorer | BioRegHub